Clinical Trials
22 trialsNCT06586957 2026-04-21
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NiKang Therapeutics, Inc.
Phase 1 Recruiting
NCT06952660 2026-04-20
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Phase 4 Recruiting
NCT03555422 2026-04-13
ENGOT-EN5
Karyopharm Therapeutics Inc
Phase 3 Completed
NCT06815939 2026-01-29
OPTICS
DL Analytics
Phase NA Recruiting
NCT07046949 2025-12-16
Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
Yuri Semenyuk Rivne Regional Clinical Hospital
Phase NA Completed
NCT04145518 2025-12-12
MCUP
Endeavor Health
Phase 4 Completed
NCT06264921 2025-09-25
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NiKang Therapeutics, Inc.
Phase 1 Terminated
NCT05453006 2025-07-10
Isbaar
University of Minnesota
Phase NA Completed
NCT03756480 2025-06-26
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
Johns Hopkins University
Active not recruiting
NCT04061967 2025-01-14
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
Karolinska Institutet
Phase NA Recruiting
NCT06692166 2024-11-22
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Recruiting
NCT05001282 2024-08-07
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Elucida Oncology
Phase 1/2 Terminated
NCT06524934 2024-07-29
Virtual Reality's Role in See&Treat Hysteroscopy
Federico II University
Phase NA Completed
NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT04679675 2023-09-18
STEP
Kaiser Permanente
Phase NA Completed
NCT03207074 2020-07-14
Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?
Imperial College London
Phase NA Completed
NCT00341458 2020-04-20
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
National Institutes of Health Clinical Center (CC)
Completed
NCT01523678 2019-07-10
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Belgian Gynaecological Oncology Group
Phase 2 Completed
NCT02139267 2017-07-12
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Genexine, Inc.
Phase 2 Completed
NCT01379534 2015-05-20
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Novartis
Phase 2 Completed
NCT01830192 2013-04-12
REM
Campus Bio-Medico University
Phase NA Completed
NCT00561795 2012-03-22
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
GlaxoSmithKline
Phase 2 Completed